Major Durable Response of Pembrolizumab in Chemotherapy Refractory Small Cell Bladder Cancer: A Case Report

Small cell carcinoma of the urinary bladder is a rare subtype (incidence of 1–9/1,000,000), characterized by an aggressive behavior with early metastasis and poor prognosis. Chemotherapy, radiation, and surgery are the usual treatment options, but to date, no accepted standard treatment exists. Sinc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Olav Toai Duc, Sundstrøm, Stein Harald, Westvik, Ganna Surzhykova, Røttereng, Ane Karoline Stræte, Melhus, Mona Røli, Bergseth, Cecilie, Hallem, Elisabeth Kvelstad, Røe, Oluf Dimitri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548951/
https://www.ncbi.nlm.nih.gov/pubmed/33082749
http://dx.doi.org/10.1159/000509747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548951/
https://www.ncbi.nlm.nih.gov/pubmed/33082749
http://dx.doi.org/10.1159/000509747

Ejemplares similares